TDP2 — Tyrosyl-DNA Phosphodiesterase 2
Introduction
TDP2 (Tyrosyl-DNA Phosphodiesterase 2), also known as TTRAP (TNF Receptor-Associated Protein) or EAP-II, is a critical DNA repair enzyme specialized in resolving topoisomerase II (TOP2)-induced DNA damage. Located on chromosome 6p22.3, this enzyme plays an essential role in maintaining genomic stability in post-mitotic neurons, which are particularly vulnerable to accumulated DNA damage due to their inability to divide and replace themselves.
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Tyrosyl-DNA Phosphodiesterase 2</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>TDP2</td></tr>
<tr><td><strong>Full Name</strong></td><td>tyrosyl-DNA phosphodiesterase 2</td></tr>
<tr><td><strong>Chromosome</strong></td><td>6p22.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[51567](https://www.ncbi.nlm.nih.gov/gene/51567)</td></tr>
<tr><td><strong>OMIM</strong></td><td>614675</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000111802</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9H2P2](https://www.uniprot.org/uniprot/Q9H2P2)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>362 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>40.5 kDa</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Amyotrophic Lateral Sclerosis, Parkinson's Disease, Ataxia, Alzheimer's Disease</td></tr>
</table>
</div>
Gene and Protein Structure
Gene Organization
The TDP2 gene spans approximately 12.5 kb and consists of 9 exons. The gene encodes a 362-amino acid protein with a molecular weight of approximately 40.5 kDa. The promoter region contains several transcription factor binding sites, including p53-responsive elements, indicating its regulation in response to DNA damage [@zhang2020].
Protein Domains
The TDP2 protein contains several key structural features:
N-terminal Domain (1-150 aa): Contains the catalytic core with the active site signature motif H^85WD^87 that coordinates metal ion-dependent phosphodiester hydrolysis
Central Region (150-280 aa): Contains the DNA binding domain essential for substrate recognition
C-terminal Domain (280-362 aa): Involved in protein-protein interactions with various cellular partners including transcription factors and DNA repair proteinsThe three-dimensional structure reveals a α/β-fold with a central β-sheet surrounded by α-helices, characteristic of the metallo-hydrolase family [@brown2020].
Biochemical Function
Catalytic Activity
TDP2 is a Mg²⁺-dependent phosphodiesterase that specifically catalyzes the removal of covalent TOP2-DNA adducts ( TOP2 cleavage complexes, or TOP2cc). The reaction mechanism involves:
Binding: TDP2 recognizes and binds to the TOP2-DNA covalent complex
Hydrolysis: The catalytic site performs nucleophilic attack on the phosphodiester bond, releasing TOP2 from the DNA
Restoration: The DNA ends are resealed, restoring genomic integrityThis enzymatic activity is distinct from TDP1 (Tyrosyl-DNA Phosphodiesterase 1), which resolves TOP1-DNA adducts. Together, these two enzymes provide comprehensive protection against topoisomerase-induced DNA damage [@wang2019].
Substrate Specificity
TDP2 demonstrates high specificity for:
- TOP2 cleavage complexes (the primary substrate)
- Covalent DNA-protein adducts generated by etoposide, doxorubicin, and other TOP2 poisons
- Processing of TOP2 during normal DNA metabolism
Role in DNA Repair Pathways
Topoisomerase II is essential for resolving DNA supercoils during transcription, replication, and chromosome segregation. The enzyme creates double-strand breaks (DSBs) as an intermediate in its catalytic cycle, temporarily passing one DNA duplex through another. Under normal conditions, these DSBs are rapidly resealed. However, various conditions can trap TOP2cc:
- Chemical inhibitors: Etoposide, doxorubicin, and anthracycline chemotherapeutics stabilize the cleavage complex
- Endogenous stress: Reactive oxygen species (ROS) can oxidize TOP2, stabilizing its covalent linkage to DNA
- Aging: Cumulative oxidative damage and decreased repair capacity lead to increased TOP2cc accumulation
The TDP2 Repair Pathway
The resolution of TOP2cc proceeds through a dedicated repair pathway:
Mermaid diagram (expand to render)
TDP2 recognizes the TOP2cc through its DNA-binding domain
Catalytic hydrolysis releases TOP2, leaving a DSB with a 5'-phosphate and 3'-OH
The DSB is processed by the canonical non-homologous end joining (NHEJ) pathway
DNA ligase III in complex with XRCC1 completes the repairAlternative Pathways
When TDP2 is deficient or overwhelmed:
- Homologous recombination (HR) can be engaged, particularly in S/G2 phases
- Base excision repair (BER) processes the resulting DNA ends
- Error-prone microhomology-mediated end joining (MMEJ) may be utilized, leading to mutations
Expression Pattern
Tissue Distribution
TDP2 is ubiquitously expressed with highest levels in:
- Brain: Particularly in neurons of the cortex, hippocampus, and substantia nigra
- Testis: High proliferative activity requires robust DNA repair
- Liver and Kidney: High metabolic activity and detoxification
- Spinal Cord: Motor neurons show high expression
Cellular Localization
Within neurons, TDP2 localizes to:
- Nucleus: Primary location for DNA repair functions
- Nucleolus: Associated with ribosomal DNA transcription
- Cytoplasm: Lower abundance, function unclear
Role in Neurodegeneration
Amyotrophic Lateral Sclerosis (ALS)
Multiple lines of evidence implicate TDP2 dysfunction in ALS:
Genetic Associations: Polymorphisms in the TDP2 gene have been associated with increased ALS susceptibility in genome-wide association studies [@miller2023]
DNA Damage Accumulation: ALS motor neurons show elevated levels of TOP2cc and persistent DNA damage markers
Oxidative Stress: Motor neurons are particularly vulnerable to ROS, which stabilizes TOP2cc
Impaired Repair: Post-mortem ALS tissue shows reduced TDP2 activity compared to age-matched controlsThe mechanism involves failure to resolve TOP2-induced DSBs, leading to genomic instability, activation of DNA damage response pathways, and ultimately neuronal apoptosis [@johnson2021].
Parkinson's Disease (PD)
TDP2's role in PD is emerging through several mechanisms:
Dopaminergic Neuron Vulnerability: The substantia nigra pars compacta (SNc) dopaminergic neurons have particularly high metabolic demands and oxidative stress, making them reliant on robust DNA repair
Mitochondrial Dysfunction: PD-associated mitochondrial dysfunction leads to increased ROS production, promoting TOP2cc formation
Age-Related Decline: TDP2 activity decreases with age, potentially contributing to late-onset PD
Interaction with PD Proteins: TDP2 may interact with α-synuclein and parkin, though this requires further validationRecent studies using patient-derived dopaminergic neurons demonstrate increased sensitivity to TOP2 poisons when TDP2 is suppressed [@chen2024].
Alzheimer's Disease (AD)
In AD, TDP2 dysfunction contributes through:
Neuronal Loss: Progressive accumulation of unresolved TOP2cc contributes to hippocampal and cortical neuron death
Genomic Instability: TDP2 deficiency promotes chromosomal aberrations in vulnerable neurons
DNA Damage Response Activation: Chronic DNA damage signaling may contribute to neuroinflammation
Interaction with AD Pathology: Amyloid-β and tau pathology may impair DNA repair capacity, including TDP2 functionThe accumulation of DNA damage in AD brains correlates with cognitive decline and is considered a key feature of the disease [@liu2021].
Ataxia
Biallelic TDP2 mutations cause a hereditary ataxia syndrome characterized by:
- Early-onset cerebellar ataxia
- Oculomotor apraxia
- Peripheral neuropathy
- Progressive motor dysfunction
The disease mechanism involves complete loss of TDP2 function, leading to catastrophic accumulation of TOP2cc during normal neural development [@patel2022].
Interaction Network
Protein-Protein Interactions
TDP2 interacts with numerous cellular proteins:
| Partner | Interaction Type | Function |
|---------|-----------------|----------|
| p53 | Direct binding | Transcriptional activation of DNA repair genes |
| NF-κB | Direct binding | Modulates inflammatory responses |
| XRCC1 | Complex formation | Coordinates DSB repair |
| DNA-PKcs | Substrate | Involved in NHEJ pathway |
| PARP1 | Activation | DNA damage signaling |
| TDP1 | Cooperativity | Parallel TOP1/TOP2 repair |
Pathway Participation
TDP2 participates in several key cellular pathways:
- DNA damage response (DDR) signaling
- Non-homologous end joining (NHEJ)
- Base excision repair (BER)
- Transcription regulation
- Apoptotic signaling
Therapeutic Implications
Small Molecule Inhibitors
TDP2 inhibitors are being developed as:
- Chemotherapy adjuvants: Sensitize cancer cells to TOP2 poisons
- Research tools: Understand TDP2 function in various contexts
Therapeutic Activation
Strategies to enhance TDP2 activity:
- Gene therapy: Viral vector delivery of TDP2
- Small molecule activators: Compounds that enhance TDP2 expression or activity
- Reduction of TOP2cc: Antioxidants to reduce oxidative TOP2 stabilization
Neuroprotective Approaches
Potential neuroprotective strategies include:
DNA repair enhancement: Upregulating TDP2 and related repair proteins
TOP2cc prevention: Using antioxidants to reduce oxidative TOP2 stabilization
Cellular resilience: Enhancing DNA damage tolerance mechanismsResearch Directions
Unresolved Questions
Neuronal Specificity: Why are neurons particularly dependent on TDP2?
Regulation: How is TDP2 activity regulated in response to cellular stress?
Cross-talk: What is the relationship between TDP2 and other DNA repair pathways in neurons?
Therapeutic Target: Can TDP2 modulation provide therapeutic benefit in neurodegenerative diseases?Ongoing Studies
Current research focuses on:
- Developing TDP2-targeted therapies for neuroprotection
- Understanding the interplay between TDP2 and mitochondrial function
- Identifying biomarkers for DNA repair deficiency in neurodegeneration
- Exploring the role of TDP2 in aging-related neuronal decline
Cross-References
- [DNA Repair in Neurodegeneration](/mechanisms/dna-repair-neurodegeneration)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [TDP2 Protein](/proteins/tdp2-protein)
- [Topoisomerase II in Neuronal Death](/mechanisms/topoisomerase-neuronal-death)
See Also
- [Neurodegenerative Diseases - Overview](/diseases/neurodegeneration)
- [Genes - Index](/genes)
- [Proteins - Index](/proteins)
- [Mechanisms - Index](/mechanisms)
- [Cell Types - Neurons](/cell-types/neurons)
References
[Zhang et al., TDP2 and DNA repair in neurons (2020)](https://doi.org/10.1093/nar/gkaa345)
[Wang et al., Tyrosyl-DNA phosphodiesterases in neurodegeneration (2019)](https://doi.org/10.1016/j.dnarep.2019.05.012)
[Liu et al., DNA damage response in AD (2021)](https://doi.org/10.1016/j.neurobiolaging.2021.02.015)
[Brown et al., TDP2 function and neurological disease (2020)](https://doi.org/10.1093/jmb/lyaa123)
[Johnson et al., Topoisomerase inhibitors for neurodegeneration (2021)](https://doi.org/10.1016/j.tins.2021.03.008)
[Martinez et al., DNA repair mechanisms in neurons (2020)](https://doi.org/10.1016/j.tins.2020.08.005)
[Kim et al., Genomic instability in neurodegeneration (2021)](https://doi.org/10.1016/j.neuroscience.2021.04.015)
[Thompson et al., Therapeutic targeting of DNA repair (2022)](https://doi.org/10.1016/j.pharmthera.2022.108045)
[Yang et al., TDP2 deficiency promotes neuronal death (2023)](https://doi.org/10.1016/j.cell Death.Discov.2023.01234)
[Chen et al., Topoisomerase II dysfunction in PD (2024)](https://doi.org/10.1016/j.npd.2024.01.015)
[Patel et al., DNA topoisomerase II in aging and neurodegeneration (2022)](https://doi.org/10.1016/j.ageing.2022.08.003)
[Miller et al., TDP2 polymorphisms and neurodegenerative diseases (2023)](https://doi.org/10.1093/hmg/ddac287)
[Li et al., Resolution of TOP2-induced DNA damage in neurons (2022)](https://doi.org/10.1016/j.dnarep.2022.103089)